Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs.

Antitubercular Agents / adverse effects Canada Chemical and Drug Induced Liver Injury / epidemiology Drug Administration Schedule Humans Isoniazid / adverse effects Latent Tuberculosis / drug therapy Quebec / epidemiology Retrospective Studies Rifampin / adverse effects

Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
03 2020
Historique:
received: 27 10 2019
accepted: 10 01 2020
pubmed: 26 1 2020
medline: 22 6 2021
entrez: 26 1 2020
Statut: epublish

Résumé

Clinical trials suggest less hepatotoxicity and better adherence with 4 months rifampin (4R)

Identifiants

DOI: 10.1183/13993003.02048-2019 PMID: 31980498
pubmed: 31980498
pii: 13993003.02048-2019
doi: 10.1183/13993003.02048-2019
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Isoniazid V83O1VOZ8L
Rifampin VJT6J7R4TR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: L.A. Ronald has nothing to disclose. Conflict of interest: J.M. Fitzgerald has nothing to disclose. Conflict of interest: G. Bartlett-Esquilant has nothing to disclose. Conflict of interest: K. Schwartzman has nothing to disclose. Conflict of interest: A. Benedetti has nothing to disclose. Conflict of interest: J-F. Boivin has nothing to disclose. Conflict of interest: D. Menzies has nothing to disclose.

Auteurs

Lisa A Ronald (LA)

Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.

J Mark FitzGerald (JM)

Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
Institute for Heart and Lung Health, University of British Columbia, Vancouver, BC, Canada.

Gillian Bartlett-Esquilant (G)

Dept of Family Medicine, McGill University, Montreal, QC, Canada.

Kevin Schwartzman (K)

Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Respiratory Epidemiology and Clinical Research Unit, and McGill International TB Centre, Montreal Chest Institute, Montreal, QC, Canada.
Dept of Medicine, McGill University, Montreal, QC, Canada.
ORCID: 0000-0002-3354-1159

Andrea Benedetti (A)

Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Respiratory Epidemiology and Clinical Research Unit, and McGill International TB Centre, Montreal Chest Institute, Montreal, QC, Canada.
Dept of Medicine, McGill University, Montreal, QC, Canada.

Jean-François Boivin (JF)

Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.

Dick Menzies (D)

Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada Dick.Menzies@Mcgill.ca.
Respiratory Epidemiology and Clinical Research Unit, and McGill International TB Centre, Montreal Chest Institute, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › Canada › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Troubles dus à des produits chimiques › Intoxication › Lésions hépatiques dues aux substances › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Calendrier d'administration des médicaments › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyridines › Acides isonicotiniques › Isoniazide › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Infection › Infection latente › Tuberculose latente › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › Canada › Québec › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Treatment with isoniazid or rifampin for...
questionsmedicales.fr › Composés polycycliques › Composés macrocycliques › Lactames macrocycliques › Rifamycine › Rifampicine › Treatment with isoniazid or rifampin for...